[1]王世兵,孟树林,武虎,等.双基因溶瘤腺病毒联合5 FU抑制肺癌细胞增殖的研究[J].浙江理工大学学报,2014,31-32(自科4):445-450.
　WANG Shi bing,MENG Shu lin,WU Hu,et al.Study on Inhibition of Lung Cancer Cell Proliferation by Combination of Dual Gene Oncolytic Adenovirus with 5 FU[J].Journal of Zhejiang Sci-Tech University,2014,31-32(自科4):445-450.

点击复制

双基因溶瘤腺病毒联合5 FU抑制肺癌细胞增殖的研究()

分享到：

参考文献/References:

［1］ Jemal A, Bray F, Center M M, et al. Global cancer statistics［J］. CA Cancer J Clin, 2011, 61(2): 69-90.
［2］ Wagstaff A J, Keam S J, McCormack P L. Bevacizumab plus platinum based chemotherapy: in advanced nonsmall cell lung cancer［J］. Bio Drugs. 2009, 23(3): 187-196.
［3］ Ranieri G, Gasparini G. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy［J］. Current Drug Targets Immune, Endocrine and Metabolic Disorders, 2001, 1(3): 241-253.
［4］ Zhang Z, Huang Y, Newman K, et al. Reexpression of human somatostatin receptor gene 2 gene mediated by oncolytic adenovirus increases antitumor activity of tumor necrosis factorrelated apoptosis inducing ligand against pancreatic cancer［J］. Clinical Cancer Research: an official journal of the American Association for Cancer Research, 2009, 15(16): 5154-5160.
［5］ Zhang Y, Gu J, Zhao L, et al. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor related apoptosis inducing ligand gene virotherapy［J］. Cancer Research, 2006, 66(8): 4291-4298.
［6］ Wang S B, Tan Y, Lei W, et al. Complete eradication of xenograft hepatoma by oncolytic adenovirus ZD55 harboring TRAIL IETD Smac gene with broad antitumor effect［J］. Human Gene Therapy, 2012, 23(9): 992-1002.
［7］ Zhang Y, Qin X, Zhang Y, et al. Combination of ZD55 MnSOD therapy with 5 FU enhances antitumor efficacy in colorectal cancer［J］. Journal of Cancer Research and Clinical Oncology, 2008, 134(2): 219-26.
［8］ Ma G, Kawamura K, Li Q, et al. Combinatory cytotoxic effects produced by E1B 55kDa deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma［J］. Cancer Gene Therapy, 2010, 17(11): 803-813.
［9］ Kadota K, Huang C L, Liu D, et al. Combined therapy with a thymidylate synthase inhibiting vector and S 1 has effective antitumor activity against 5 FU resistant tumors［J］. International Journal of Oncology. 2011, 38(2): 355-63.
［10］ Keane M M, Ettenberg S A, Nau M M, et al. Chemotherapy augments TRAIL induced apoptosis in breast cell lines［J］. Cancer research, 1999, 59(3): 734-741.
［11］ Ashkenazi A, Pai R C, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand［J］. The Journal of Clinical Investigation, 1999, 104(2): 155-162.
［12］ Mizutani Y, Nakanishi H, Yoshida O, et al. Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL mediated apoptosis by subtoxic concentrations of 5 fluorouracil［J］. European Journal of Cancer, 2002, 38(1): 167-176.